Wockhardt USA Competitors and Similar CompaniesClear all
Wockhardt USA's competitors and similar companies include UCB, Mankind Pharma, Alembic Pharmaceuticals and Livzon Pharmaceutical Group.
 UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. |  Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines. |  Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ||
Founding Date | Founding Date 2004 | Founding Date 1928 | Founding Date 1995 | Founding Date 2010 | Founding Date 1985 |
Type | Type Subsidiary | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Parsippany-Troy Hills, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations New Delhi, IN HQ | Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN |
Employees | Employees 103 | Employees 9,052 | Employees 16,2532% increase | Employees 14,858 | Employees 9,067 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₹73.4b (FY, 2026) | Revenue (est.) ¥11.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) | Cost of goods N/A | Cost of goods ₹19.8b (FY, 2026) | Cost of goods ¥4.1b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit €7.2b (FY, 2025) | Gross profit N/A | Gross profit ₹54.1b (FY, 2026) | Gross profit ¥7.8b (FY, 2025) |
Net income | Net income N/A | Net income €1.6b (FY, 2025) | Net income N/A | Net income ₹6.7b (FY, 2026) | Net income ¥2.4b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View companyMankind Pharma
HQ
New Delhi, IN
Employees
16,253↑ 2% increase
Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.
View companyAlembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View company